Invasive Candidiasis.

Invasive candidiasis is the most common fungal disease among hospitalized patients in the developed world. Invasive candidiasis comprises both candidemia and deep-seated tissue candidiasis. Candidemia is generally viewed as the more common type of the disease, and it accounts for the majority of cases included in clinical trials. Deep-seated candidiasis arises from either hematogenous dissemination or direct inoculation of candida species to a sterile site, such as the peritoneal cavity (Fig. 1). Mortality among patients with invasive candidiasis is as high as 40%, even when patients receive antifungal therapy. In addition, the global shift in favor of nonalbicans candida species is troubling, as is the emerging resistance to antifungal drugs. During the past few years, new insights have substantially changed diagnostic and therapeutic strategies.

• Publication year

  2019

• Venue

  New England Journal of Medicine

• Publication date

  2019-03-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMra1315399PMID 26444731
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Candiduria: Evidence-based approach to management, are we there yet?

  2017cited by this paper
• Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance

  2015cited by this paper
• T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial.

  2015cited by this paper
• Use and Limits of (1-3)-β-d-Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis

  2014cited by this paper
• Prophylactic Echinocandin: Is There a Subgroup of Intensive Care Unit Patients Who Bene fi t?

  2014cited by this paper
• Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010)

  2014cited by this paper
• Echinocandin resistance: an emerging clinical problem?

  2014cited by this paper
• MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.

  2014cited by this paper
• Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU

  2014cited by this paper
• Immunotherapy: a potential adjunctive treatment for fungal infection

  2014cited by this paper
• Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*

  2014cited by this paper
• Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia

  2014cited by this paper
• Multistate point-prevalence survey of health care-associated infections.

  2014cited by this paper
• Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

  2014cited by this paper
• The Danish Collaborative Bacteraemia Network (DACOBAN) database

  2014cited by this paper
• Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation

  2014cited by this paper
• Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance

  2014cited by this paper
• Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients.

  2014cited by this paper
• Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.

  2013cited by this paper
• Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.

  2013cited by this paper
• β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

  2013cited by this paper
• Performance of Candida Real-time Polymerase Chain Reaction, β-d-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis

  2013cited by this paper
• Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis – A Systemic Review and Meta-Analysis

  2013cited by this paper
• Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

  2013cited by this paper
• Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.

  2013cited by this paper
• Cytokine gene polymorphisms and the outcome of invasive candidiasis: a prospective cohort study.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

  2012cited by this paper
• Toll-like receptor 1 polymorphisms increase susceptibility to candidemia.

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

  2012cited by this paper
• β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

  2012cited by this paper
• ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

  2012cited by this paper
• Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.

  2012cited by this paper
• Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients

  2012cited by this paper
• Septic shock attributed to Candida infection: importance of empiric therapy and source control.

  2012cited by this paper
• Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials.

  2012cited by this paper
• Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia

  2012cited by this paper
• Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

  2011cited by this paper
• Microsatellite multilocus genotyping clarifies the relationship of Candida parapsilosis strains involved in a neonatal intensive care unit outbreak.

  2011cited by this paper
• Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

  2011cited by this paper
• β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

  2011cited by this paper
• Epidemiology of invasive candidiasis

  2010cited by this paper
• Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials.

  2010cited by this paper
• Should the guidelines for management of central venous catheters in patients with candidemia be changed now?

  2010cited by this paper
• PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis

  2010cited by this paper
• The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia

  2010cited by this paper
• Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials

  2010cited by this paper
• Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

  2010cited by this paper
• Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005–2006)

  2009cited by this paper
• Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients

  2009cited by this paper
• Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

  2009cited by this paper
• Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.

  2009cited by this paper
• Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

  2009cited by this paper
• Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.

  2007cited by this paper
• Anidulafungin versus fluconazole for invasive candidiasis.

  2007cited by this paper
• Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.

  2007cited by this paper
• Voriconazole Versus a Regimen of Amphotericin B Followed by Fluconazole for Candidaemia in Nonneutropenic Patients: A Randomised Noninferiority Trial

  2006cited by this paper
• Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.

  2006cited by this paper
• Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

  2005cited by this paper
• Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*

  2005cited by this paper
• Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

  2005cited by this paper
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

  2003cited by this paper
• Duration of Antifungal Treatment and Development of Delayed Complications in Patients with Candidaemia

  2003cited by this paper
• Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species.

  2002cited by this paper
• In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model

  2002cited by this paper
• Comparison of caspofungin and amphotericin B for invasive candidiasis.

  2002cited by this paper
• Double-Blind Placebo-Controlled Trial of Fluconazole to Prevent Candidal Infections in Critically Ill Surgical Patients

  2001cited by this paper
• Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients.

  1999cited by this paper
• A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.

  1994cited by this paper
• A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

  1994cited by this paper
• Diagnostic Procedures

  1973cited by this paper

• Multiplex on-chip detection of Aspergillus by integrated ultrasonication-based bead beating lysis and magnetic beads direct amplification.

  2026cites this paper
• Gene expression profiling of the carbon pathways and virulence factors of Candida albicans in different carbon sources.

  2026cites this paper
• Spinal Cord Involvement in Patients with Adult-Onset Multiple Acyl-CoA Dehydrogenase Deficiency

  2026cites this paper
• Cost‐Effectiveness of Once Weekly Rezafungin for the Treatment of Invasive Candidiasis in the United Kingdom

  2026cites this paper
• Antifungal Activity of Natural Thymol: Advances on Molecular Mechanisms and Therapeutic Potential

  2026cites this paper
• Ophthalmic Evaluation and Ocular Candidiasis in Patients with Candidemia: A Retrospective Cohort Study from Thailand

  2026cites this paper
• Recombinant AMPs (Epinecidin-1 and its Variants): A New Hope against Invasive Fungal Infections against Candida spp. and Aspergillus flavus

  2026cites this paper
• In vitro activity of eight antifungal drugs against clinical and hospital isolates of Candida parapsilosis complex; a multicenter study, 2023–2024

  2026cites this paper
• Lavandula angustifolia Essential Oil as a Developmental Inhibitor of Candida Species and Biofilms

  2026cites this paper
• Synthesis, Characterization, Density Functional Theory Calculation, In Silico and In Vitro Antimicrobial Evaluation of New 1,2,4‐Triazole‐Amide Conjugates

  2026cites this paper
• Emergent Candida Species on Healthcare Surfaces: Abiotic Reservoirs as a Source of Invasive Candidiasis.

  2026cites this paper
• Clinical and molecular features of candidemia: a three-year retrospective study in Northern Guizhou, China

  2026cites this paper
• Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans.

  2026cites this paper
• Identification and antifungal susceptibility pattern of Candida species isolated from a tertiary hospital in Irrua, Edo State, Nigeria.

  2026cites this paper
• Non-C. albicans Candida Species Develop Clinically Relevant Biofilms on Stainless Steel Under Respiratory Tract-Mimicking Conditions

  2026cites this paper
• Targeting multidrug-resistant Candida: CuxTe nanoflowers synergistically facilitate fungal clearance via cuproptosis death and host immune activation

  2026cites this paper
• Fluconazole-resistant Candida parapsilosis: a global threat with increasing relevance in Argentina.

  2026cites this paper
• Compromising UPD-sugar nucleotide biosynthesis attenuates Candida albicans viability, virulence and drug sensitivity.

  2026cites this paper
• In silico screening of IMPPAT-derived phytochemicals targeting ERG6 and drug resistance–associated proteins in drug-resistant Candida albicans: virtual screening and molecular dynamics using alphafold models

  2026influential citation
• Risk Factors of Mortality in Older Patients With Candidemia

  2026cites this paper
• Hepatic Candidiasis in a Non-neutropenic Patient

  2026cites this paper
• Clinical and Molecular Epidemiological Characteristics of 26 Bloodstream Infection Cases Caused by Candida tropicalis

  2025cites this paper
• Pathogenicity Evaluation on Fluconazole-Resistant Candida auris Clade V in Murine Model

  2025cites this paper
• Invasive Candidiasis in Children

  2025cites this paper
• Early-Onset Candidemia in Adult Intensive Care Units

  2025cites this paper
• Expansion, functional diversification and gene fusion events in the Ato protein family

  2025influential citation
• Candida albicans Aortic Fungus Ball in a Behçet’s Disease Patient

  2025cites this paper
• Finding Acridone as Potent Antifungal Ligand Targeting Virulent Proteins of Fungal Pathogen Candida albicans

  2025cites this paper
• Peering Inside the Black Box: Explainable AI to Interpret Advanced Computer Vision Fungal Pathogen Prediction

  2025cites this paper
• Endogenous Candida Endophthalmitis: An Update on Epidemiological, Pathogenetic, Clinical, and Therapeutic Aspects

  2025cites this paper
• Current Overview of Environmental Disinfection and Decolonization of C. auris: A Systematic Review from 2020 to 2025

  2025cites this paper
• Integrative Gene Expression Analysis to Identify Potential Biomarkers in Candida Pathogenesis

  2025cites this paper
• Management of invasive candidiasis in French ICUs: insights from a 2024 nationwide survey

  2025cites this paper
• In vitro investigation on nanosilver-Moringa oleifera of optical characteristics, photoantimicrobial activity, and damage profile against Candida albicans biofilm.

  2025cites this paper
• Multidrug-Resistant Candida in Bloodstream Infections: A Growing Concern in Indian Healthcare

  2025cites this paper
• Discovery of semisynthetic derivatives of (R)- and (S)-usnic acids as potential antifungal agents against C. tropicalis and T. rubrum

  2025cites this paper
• Endophytic fungi-bioinspired nanoparticles potential to control infectious disease

  2025cites this paper
• Proximity labeling identification of plasma membrane eisosome proteins in Candida albicans

  2025cites this paper
• Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review

  2025cites this paper
• Variations in adverse events associated with different infusion modalities of parenteral nutrition: A pharmacovigilance study.

  2025cites this paper
• Acupuncture Ameliorates Alzheimer’s-Like Cognitive Impairment and Pathological Changes via Regulating the Intestinal Fungal Community in APP/PS1 Mice

  2025cites this paper
• Ligand-Based Drug Discovery Leveraging State-of-the-Art Machine Learning Methodologies Exemplified by Cdr1 Inhibitor Prediction

  2025cites this paper
• Candidemia y candidiasis invasiva

  2025cites this paper
• Antibiofilm and antifungal properties of SrWO4 microstructures against multi-azole-resistant Candida albicans and other microbes

  2025cites this paper
• Effects of Ire1 gene on virulence and pathogenicity of Candida albicans

  2025cites this paper
• Creating a prediction model for invasive candidiasis in the intensive care unit using a case control design: a European multicentre approach

  2025cites this paper
• An integrated bioinformatics and machine learning-based approach to depict key immunological players associated with candidemia during immunodeficiency

  2025cites this paper
• Current Progression in Nanomedicine for the Treatment of Candida albicans Infections

  2025cites this paper
• The Impact of Epidemiological Trends and Guideline Adherence on Candidemia-Associated Mortality: A 14-Year Study in Northeastern Italy

  2025cites this paper
• Synthesis of the New Chemical Marker, [Eu(DBM)3(Lap), and Design Via Molecular Docking for Use in Recognition of Candida auris Polymerase

  2025cites this paper
• Population-Based Active Surveillance for Culture-Confirmed Candidemia — 10 Sites, United States, 2017–2021

  2025cites this paper
• Epidemiology of Candidemia: Experience of the Parasitology-Mycology Laboratory at CHU Mohamed VI of Marrakech, Morocco

  2025cites this paper
• CRISPR-Cas9 RNP-Mediated Deletion of ERG25 in Non-albicans Candida Species, Including Candida auris.

  2025cites this paper
• Neonatal Invasive Candidiasis: Current Concepts

  2025cites this paper
• Epidemiology of Candidemia, Candiduria and Emerging Candidozyma (Candida) auris Across Gulf Cooperative Council Countries and Yemen in the Arabian Peninsula

  2025cites this paper
• Candida albicans: Insights into the Biology and Experimental Innovations of a Commonly Isolated Human Fungal Pathogen.

  2025cites this paper
• [First case of Candida glabrata endocarditis in Greenland].

  2025cites this paper
• Crosstalk between iron and flavins in the opportunistic fungal pathogen Candida albicans

  2025cites this paper
• Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?

  2025cites this paper
• Polygenetic Determinants of Azole Resistance, Tolerance, and Heteroresistance in Candida albicans

  2025cites this paper
• Synthetic Human Lactoferrin Peptide hLF(1-11) Shows Antifungal Activity and Synergism with Fluconazole and Anidulafungin Towards Candida albicans and Various Non-Albicans Candida Species, Including Candidozyma auris

  2025cites this paper
• Combined genetic and environmental factors shape the landscape of anti-fungal tolerance in Nakaseomyces glabratus

  2025cites this paper
• Induction of Antifungal Tolerance Reveals Genetic and Phenotypic Changes in Candida glabrata

  2025cites this paper
• Candida infections in COVID-19 patients: A review of prevalence, risk factors, and mortality.

  2025cites this paper
• The role of glycosylated mucins in maintaining intestinal homeostasis and gut health

  2025cites this paper
• Successful rezafungin treatment of an azole-resistant Candida parapsilosis vascular graft infection

  2025cites this paper
• Nakaseomyces glabratus (Candida glabrata) MLST Genotypes in Central Poland

  2025cites this paper
• Supervised Machine Learning for Cell Classification in Microwave Flow Cytometers

  2025cites this paper
• Relationship Between Steroid and Antibiotic Therapy and the Frequency of Oral Candidiasis

  2025cites this paper
• Biofilm-Associated Candidiasis: Pathogenesis, Prevalence, Challenges and Therapeutic Options

  2025cites this paper
• ANIDULAFUNGIN AND HUMAN MONOCYTES REDUCE Candida spp. BIOFILM WITH DIFFERENT FUNGAL BIOMASS

  2025cites this paper
• Fungal Infections in People Who Use Drugs

  2025cites this paper
• Mucocutaneous Defense Mechanisms against Candida Infection

  2025cites this paper
• Elimination of Candida Sepsis and Reducing Several Morbidities in a Tertiary NICU in Greece After Changing Antibiotic, Ventilation, and Nutrition Protocols

  2025cites this paper
• Epidemiology and Clinical Features of Candida Bloodstream Infections: A 10-Year Retrospective Study in a Korean Teaching Hospital

  2025cites this paper
• Candida auris: A Continuing Threat

  2025cites this paper
• Anacardiaceae Family: Effect of Isolated Compounds and Other Identified Phytochemicals Against Clinically Relevant Candida Species—A Short Review

  2025cites this paper
• Fungal Pericarditis—A Systematic Review of 101 Cases

  2025cites this paper
• Invasive Candidiasis in the Intensive Care Unit: Where Are We Now?

  2025influential citation
• Assessment of incidence and risk factors of COVID-19-associated candidemia using diagnosis procedure combination data.

  2025cites this paper
• Synergistic antifungal activity of minocycline as an effective augmenting agent of fluconazole against drug-resistant Candida tropicalis

  2025cites this paper
• Kazachstania slooffiae Fungemia: A Case Report and Literature Review on an Emerging Opportunistic Pathogen in Humans

  2025cites this paper
• Roles of P-body factors in Candida albicans filamentation and stress response

  2025cites this paper
• Isolation and characterization of a phage against the multidrug-resistant Candida albicans ATCC 10231 strain from raw sewage.

  2025cites this paper
• Antifungal activity of polyphenolic compounds against fluconazole-susceptible and -resistant Candida species

  2025cites this paper
• Antifungal Activity and Cytotoxicity of Imidazole- and Morpholine-Based Lysosomotropic Detergents

  2025cites this paper
• An Optimized LIVE/DEAD Assay Using Flow Cytometry to Quantify Post-Stress and Antifungal-Treatment Survival in Diverse Yeasts

  2025cites this paper
• Concurrent invasive disseminated Nocardia farcinica and Candida infections in a patient undergoing long-term glucocorticoid therapy for autoimmune thrombocytopenia: a case report

  2025cites this paper
• Development of a novel family of antifungal agents based on a quinone methide oxime framework

  2025cites this paper
• Candidemia in Left Ventricular Assist Device Recipients: Incidence, Risk Factors, and Outcomes

  2025cites this paper
• CVF1 Promotes Invasive Candida albicans Infection via Inducing Ferroptosis

  2025cites this paper
• Nanotechnology-driven synergy: research effects of curcumin nanosuspension and fluconazole combination in overcoming azole resistance in Candida albicans

  2025cites this paper
• The S862C amino acid change in CpMrr1 confers fluconazole resistance in Candida parapsilosis

  2025cites this paper
• Synthesis, characterization, and microbiological evaluation of new triazolopyrimidine-based ferrocenes as potent antimicrobial prospects.

  2025cites this paper
• Evaluation of the Synergistic Activity of Antimicrobial Peptidomimetics or Colistin Sulphate with Conventional Antifungals Against Yeasts of Medical Importance

  2025cites this paper
• Genetic Epidemiology and Resistance Investigations of Clinical Yeasts in Alexandria, Egypt

  2025cites this paper
• Absence of community-acquired Candida auris colonization among newly hospitalized participants without recent healthcare exposure from a cross-sectional study in Dhaka, Bangladesh

  2025cites this paper
• Antimicrobial Resistance in Sub-Saharan Africa: A Comprehensive Landscape Review

  2025cites this paper
• Fungal sepsis in a 7-month-old female: diagnosis through peripheral blood smear

  2025cites this paper
• CO2 potentiates echinocandin efficacy during invasive candidiasis therapy via dephosphorylation of Hsp90 by Ptc2 in condensates

  2025cites this paper